References

1. World Health Organization (WHO). 2001. Rheumatic fever and Rheumatic Heart Disease: report of a WHO Study Group. Geneva, (Technical Report Series , No.923);

2. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population based study. Lancet 2006;368:1005-1011;

3. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular Disease. In: Jamison DT, Breman JG, Measham AR, et al. editors. Disease Control Priorities in Developing Countries 2nded. The International Bank for Reconstruction and Development/ The World Bank. Washington

DC. 2006. P. 645-662;

4. Hewitson J, Zilla P. Children’s heart disease in Sub-Saharan Africa: Challenging the burden of disease. SA Heart 2010;7:18-29;

5. Zuhlke L, Mirabel M, Marijon E. Congenital heart disease and rheumatic heart disease in Africa: recent advances and current priorities. Heart 2013;99:1554-1561;

6. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: A European experience. Current Probl Cardiol, November 2007. P. 609-66;

7. Marcus RH, Sareli P, Pocock WA, Barlow JB. The spectrum of severe rheumatic mitral valve disease in a developing country. Ann

Intern Med 1994;120:177-183;

8. Outcomes 2011. Cleveland Clinic Heart and Vascular Institute;

9. Outcomes 2008. Fu Wai Hospital.Dept. of Cardiovascular Surgery of National Cardiovascular Center. Beijing, China;

10. Wang L, Kong L, WU F, Bai Y, Burton R. Preventing chronic diseases in China. Lancet 2005;366:1821-1824;

11. Lee R, LI, S, Rankin JS, et al. Fifteen-year outcome trends for valve surgery in North America. Ann Thorac Surg 2011;91:677-684

12. Hurst JW. The value of using the entire New York Heart Association classification of heart and vascular Disease. Clin Cardiol 2006;29:415-417;

13. Nishimura RA, Otto CN, Bonow RO, et al. Guidelines for the management of patients with valvular heart disease: Executive summary: A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines. Circulation 2014;129:e521-e643;

14. Chikwe J, Beddow E, Glenville. Cardiothoracic Surgery.Oxford University Press. Oxford, UK. 2006. P.364-425;

15. Chizner MA. Cardiac auscultation: Rediscovering the lost art. Curr Prob Cardio 2008;33:317-408;

16. Carabello BA. Modern management of mitral stenosis. Circulation. 2005;112:432-437;

17. Marijon E, OU P, Celermajer DS, et. al. Prevalence of rheumatic heart disease detected by echocardiographic screening. N Eng J Med 2007;357:470-476;

18. Marijon E, Celemajer DS, Tafflet M, El-Haou S, Jani DN, Ferreira B, et al. Rheumatic heart disease screening by Echocardiography. Circulation 2009;120:663-668;

19. Chandrashekhar Y, Westaby S, Narula J. Mitral stenosis. Lancet  2009;374:1271-1283;

20. Oh JK, Seward JB, Tajik AJ. The ECHO Manual, 3rd ed. Wolters Kluwer/ Lippincott Williams & Wilkins. Philadelphia. 2007;

21. Kirkpatrick JN, Lang RM. Surgical

echocardiography of heart valves: a primer

for the cardiovascular surgeon. Semin

Thoracic Surg 2010;22:200-215;

22. Houck RC, Cooke JE, Gill EA. Live 3D

Echocardiography: A replacement for

traditional 2D Echocardiography? AJR

2006;187:1092-1106;

23. Lang RM, Tsang W, Weinert L, Mor-Avi,

Chandras S. Valvular heart disease- The value of 3-dimentional echocardiography. J

Am Coll Cardiol 2011;58:1933-1944;

24. Leong DP, Joseph MX, Selvanayagam JB.

The evolving role of multimodality imaging in

valvular heart disease. Heart 2014;100:336-

346;

25. Grossman W. Profiles in Valvular Heart

Disease. In: Baim DS, Grossman W. editors.

Grossman’s Cardiac Catheterization,

Angiography, and Intervention.6th ed.

Lippincott Williams and Wilkins.A Woltors

Kluwer Co. Philadelphia, PA. 2000. P. 759-

783;

26. Otto M. IN: Otto CM, Bonow RO editors.

Valvular Heart Disease. A Companion to

Braunwald’s Heart Disease, 4th edition.

Elsevier/ Saunders. Philadelphia, PA. 2014.

P.119-133;

27. The Joint Task Force on the Management

of Valvular Heart Disease of the European

Society of Cardiology (ESC) and the

European Association for Cardio-Thoracic

Surgery (EACTS) Guidelines on the

management of valvular heart disease

(version 2012). European Heart Journal

2012; 33, 2451–2496.www.escardio.org/

guidelines;

28. Selzer A, Cohn KE. Natural history of mitral

stenosis: A review. Circulation 1972;40:878-

884;

29. Diagnosis and Management of Heart

Failure in Adults http://circ.ahajournals.org/

content/119/14/1977.full.pdf ;

30. ACC/AHA Guidelines for Atrial Fibrillation.

http://my.americanheart.org/idc/groups/

ahamah-public/@wcm/@sop/@spub/

documents/downloadable/ucm_427314.pdf

(Accessed March 4, 2013);

31. Berkowitz, FE: Infective endocarditis: In

Nichols EG, Cameron DE, Greeley WJ, et

al. (eds). Critical Heart Disease in Infants

and Children. St. Louis, Mosby-Year Book;

32. Iung B, Vahanian A. Rheumatic mitral valve

disease. In: Otto CM, Bonow RO editors.

Valvular Heart Disease. A Companion to

Braunwald’s Heart Disease, 4th edition.

Elsevier/ Saunders. Philadelphia, PA. 2014;

P.255-277;

33. Krishnaswamy A, Kapadia S. Percutaneous

mitral valve repair. In: Topol EJ, Teirstein-,

editors. Textbook of Interventional

Cardiology. Elsevier/ Saunders. 6th edition.

Philadelphia, PA. 2012. P. 647-660;

34. Nobuyoshi M, Arita T, Shira S, et al.

Percutaneous balloon mitral valvuloplasty:

a review. Circulation 2009;119:e211-e219;

35. Carroll JD, Gaasch WH. Up To Date.

Percutaneous mitral balloon valvotomy for

mitral stenosis. http://www.uptodate.com/

contents/percutaneous-mitral-balloonvalvotomy-

for-mitral-stenosis. (Accessed

2/15/15);

36. Padial LR, Freitas N, Sagie A, et al.

echocardiography can predict patients who

develop severe mitral regurgitation following

percutaneous mitral balloon valvuloplasty. j

am coll cardiol 1996;27:1225-1231;

37. Soliman OII, Anwar AM, Metawei AK,

McGhie JS, Geleijnse ML, TenCate FJ. New

scores for the assessment of mitral stenosis

using Real-Time Three Dimensional

Echocardiography. Curr Cardiovasc Imaging

Rep 2011;4:370-377;

38. Inoue K, Owaki T, Nakamura T, Kitamura

F, Miyamoto N. Clinical application of

transvenous mitral commissurotomy by a

new balloon catheter. J Thorac Cardiovasc

Surg 1984;87:394-402;

39. Lock JE, Khalilullah M, Shrivastavas S, et

al. Percutaneous catheter commissurotomy

in rheumatic stenosis. N Engl J Med

1985;313:1515- 1518;

40. The National Heart, Lung, and Blood

Institute Balloon Valvuloplasty Registry

Participants. Multicenter experience with

balloon mitral commissurotomy. NHLBI

balloon valvulplasty registry report on

immediate and 30-day follow-up results.

Circulation 1992;85:448-461.

41. Al-Zabag M, Ribeiro PA, Al-Kasab S, Al-

Fagih MR. Percutaneous double balloon

mitral valvotomy for rheumatic mitral

stenosis. Lancet 1986;1:757-761;

42. Palacios IF, Tuzcu ME, Weyman AE, Newell

JB, Block PC. Clinical follow-up of patients

undergoing percutaneous mitral balloon

valvotomy. Circulation 1995;91:671-676;

43. Bonhoeffer P, Esteves C, Casal U, et al.

Percutaneous mitral valve dilatation with the

Multi-Track System. Catheter Cardiovasc

Interv. Oct 1999;48(2):178-183;

44. Cribier A, Eltchaninoff H, KONING R,

et al. Percutaneous mechanical mitral

commissurotomy with a newly designed

metallic valvulotome: immediate results

of the initial experience in 153 patients.

Circulation 1999;99:793-799;

45. Assadi R. Percutaneous Mitral Balloon

Valvuloplasty. Medscape. http://emedicine.

m e d s c a p e . c o m / a r t i c l e / 1 8 3 9 6 7 7 -

overview#showall\ ;

46. Vahanian A, Himbert D, Brochet E, Iung B.

Mitral valvuloplasty. In: Topol EJ, Teirstein-,

editors. Textbook of Interventional

Cardiology. Elsevier/ Saunders. 6th edition.

Philadelphia, PA. 2012. P. 635-646;

47. Green NE, Hansgen AR, Carroll JD.

Initial clinical experience with intracardiac

echocardiography in guiding balloon

valvuloplasty: technique, safety, utility, and

limitations. Catheter Cardiovasc Interv

2004;63:385- 394;

48. Iung B, Cormier B, Ducimetiere P, et al.

Functional results 5 years after successful

percutaneous mitral commissurotomy

in a series of 528 patients and analysis

of predictive factors. J Am Coll Cardiol

1996;27:407-414;

49. Fawzy ME. Long-term results up to 19

years of mitral balloon valvuloplasty. Asian

Cardiovasc Thorac Ann 2009;17:627-633;

50. Palacios IF, Sanchez PL, Harrell LC,

et al. Which patients benefit from

percutaneous mitral balloon valvuloplasty?

Prevalvuloplasty and postvalvuloplasty

variables that predict long-term outcome.

Circulation 2002;105:1465-1471;

51. Zimmet AD, Almeida AA, Harper RW, et al.

Predictors of surgery after percutaneous

mitral valvuloplasty. Ann Thorac Surg

2006;82:828-833.

52. Bouleti C, Iung B, Laouenan C, et al.

Late results of percutaneous mitral

commissurotomy up to 20 years:

development and validation of a risk score

predicting late functional results from a series

of 912 patients. Circulation 2012;125:2119-

2127;

53. Song JK, Kim MJ, Yun SC, et. al. Longterm

outcomes of percutaneous balloon

valvuloplasty versus open cardiac surgery.

J Thorac Cardiovasc Surg 2010; 139:103-

11041;

54. Antunes MJ, Nascimento J, Andrade

CM, Fernandes LE. Open mitral

commissurotomy: A better procedure? J

Heart Valve Dis 1994;3:88-92.

55. Acar J. Editorial: Open mitral commissurotomy

or percutaneous mitral commissurotomy? J

Heart Valve Dis 1994;3:133-135,

56. Cotrufo M. Renzulli A, Ismeno G, et al.

Percutaneous mitral commisssurotomy

versus open mitral commissurotomy: a

comparative study. Europ J Cardiothorac

Surg 1999;15:646-652. 51,

57. Turgeman Y, Atar S, Suleiman K, et al.

Feasibility, safety, and morphologic predictors

of outcome of repeat percutaneous balloon

mitral commissurotomy. Am J Cardiol

2005;95:989-991,

58. Herrmann HC. Transcatheter mitral valve

repair and replacement. In: Otto CM,

Bonow RO editors. Valvular Heart Disease.

A Companion to Braunwald’s Heart

Disease, 4th edition. Elsevier/ Saunders.

Philadelphia, PA. 2014. P.341-352.